Gary R. Conrad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gary R. Conrad has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Partha Sinha
5 shared publicationsDavid A. Sloan
1 shared publicationMarkus Holzhauer
1 shared publicationP Sinha
1 shared publication
Latest Publications
- 1 January 2005
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 30 (1) , 35-36
FDG PET Imaging of Subependymal Gray Matter Heterotopia
A 25-year-old woman underwent interictal F-18 FDG PET for evaluation of long-standing intractable epilepsy. She had no sign or family history of tuberous sclerosis, and she demonstrated no interictal neurologic deficit. PET showed periventricular and deep white matter FDG metabolism that was congruent anatomically to the pattern of nodular gray matter heterotopia (GMH) demonstrated on MRI. This case adds information concerning the spectrum of interictal FDG metabolism within GMH, when it is performed without activation task. It further illustrates the importance of recognizing GMH to avoid their misinterpretation as independent, subclinical ictal foci.
- 1 January 2005
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 30 (1) , 35-36
FDG PET Imaging of Subependymal Gray Matter Heterotopia
A 25-year-old woman underwent interictal F-18 FDG PET for evaluation of long-standing intractable epilepsy. She had no sign or family history of tuberous sclerosis, and she demonstrated no interictal neurologic deficit. PET showed periventricular and deep white matter FDG metabolism that was congruent anatomically to the pattern of nodular gray matter heterotopia (GMH) demonstrated on MRI. This case adds information concerning the spectrum of interictal FDG metabolism within GMH, when it is performed without activation task. It further illustrates the importance of recognizing GMH to avoid their misinterpretation as independent, subclinical ictal foci.
- 1 November 2004
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 29 (11) , 717-719
Perineural Spread of Skin Carcinoma to the Base of the Skull: Detection With FDG PET and CT Fusion
A 66-year-old man underwent 2-F-18 fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) for evaluation of new-onset left jaw pain approximately 5 years after the diagnosis of squamous cell carcinoma of the lower lip. His initial surgery included a Mohs excision. As a result of tumor invasion, he subsequently underwent resection of his left lower lip, chin, and cheek as well as segmental mandibulectomy. Reconstruction included a Synthes plate and platysmal mucocutaneous flap. One week before the FDG PET scan, he underwent contrast computed tomography (CT) of the neck, which revealed enhancement of the left medial pterygoid muscle and widening of the mandibular foramen of the ipsilateral mandible. PET showed FDG hypermetabolism in the floor of the mouth near the site of the mandibular resection. PET also showed hypermetabolism tracking in the lateral face to the skull base. Fusion of PET with CT demonstrated this hypermetabolism to follow the course of the mandibular division of the trigeminal nerve (V3). Exploratory surgery and accompanying histopathology confirmed the suspected recurrence of squamous cell carcinoma within pterygoid musculature, as well as the imaging diagnosis of perineural spread along V3. A search of the medical literature reveals no prior report of large perineural spread diagnosed with FDG PET using PET/CT fusion.
- 1 November 2004
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 29 (11) , 717-719
Perineural Spread of Skin Carcinoma to the Base of the Skull: Detection With FDG PET and CT Fusion
A 66-year-old man underwent 2-F-18 fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) for evaluation of new-onset left jaw pain approximately 5 years after the diagnosis of squamous cell carcinoma of the lower lip. His initial surgery included a Mohs excision. As a result of tumor invasion, he subsequently underwent resection of his left lower lip, chin, and cheek as well as segmental mandibulectomy. Reconstruction included a Synthes plate and platysmal mucocutaneous flap. One week before the FDG PET scan, he underwent contrast computed tomography (CT) of the neck, which revealed enhancement of the left medial pterygoid muscle and widening of the mandibular foramen of the ipsilateral mandible. PET showed FDG hypermetabolism in the floor of the mouth near the site of the mandibular resection. PET also showed hypermetabolism tracking in the lateral face to the skull base. Fusion of PET with CT demonstrated this hypermetabolism to follow the course of the mandibular division of the trigeminal nerve (V3). Exploratory surgery and accompanying histopathology confirmed the suspected recurrence of squamous cell carcinoma within pterygoid musculature, as well as the imaging diagnosis of perineural spread along V3. A search of the medical literature reveals no prior report of large perineural spread diagnosed with FDG PET using PET/CT fusion.
- 1 November 2003
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 24 (11) , 1129-1137
Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy
Dual time-point imaging has been proposed as a means of improving the accuracy of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) for the diagnosis of malignant pulmonary nodules. The purpose of this study was to evaluate a dual time-point protocol that has a narrow time window between its initial and its delayed imaging sessions. All patients examined during a 16-month time period, either for the diagnosis of a radiographically indeterminate thoracic lesion or for the staging of non-small-cell carcinoma, were included in the study provided that they completed the dual-point protocol and had either biopsy evidence of malignancy, biopsy evidence of a benign condition involving the thoracic lesion of concern, or clinical and radiographic follow-up consistent with the absence of malignancy. The entire study population was further divided into a central subpopulation, whose index lesions were adjacent to or within the hilum or mediastinum, and a peripheral subpopulation, whose index lesions were non-central. The maximum standardized uptake value (SUV) was measured for each lesion, and various body surface areas (BSAs) and glucose corrections on the SUV were compared using discriminant analysis. BSA corrected SUVs for the initial (iSUV) and the delayed (dSUV) imaging sessions, along with their absolute difference (δSUV) and fractional difference (fSUV) were also compared using discriminant analysis and receiver operating characteristic (ROC) analysis. The study population consisted of 132 patients, of whom 81 had malignancy and 51 were classified as having a benign condition. Thirty-three index lesions were central and 99 were peripheral; 109 had visible uptake and 23 had such low uptake that they were not visible above background. The mean time (±SD) between initial and delayed imaging for the visible lesions was 31.1±9.4 min. With respect to the entire study population, the BSA replacement for body weight gave the best performance among the various SUV corrections examined. In addition, the BSA corrected delayed SUV (dSUV) gave a performance superior to either initial SUV (iSUV), absolute difference in SUV (δSUV) and fractional difference in SUV (fSUV) alone. Performance gains achieved by BSA correction and by dSUV appeared to derive primarily from the central subpopulation, thereby indicating that central lesions tend to behave differently to peripheral ones. For the central subpopulation, ROC analysis also demonstrated improved detection of malignancy from dual-point imaging. The best performance was achieved when the BSA corrected dSUV was at least 2.4, or when the fSUV showed at least a 5% increase from initial to delayed imaging. With the optimal combined dSUV/fSUV strategy, the area under the ROC curve was 0.99, as opposed to 0.96 for dSUV alone, or 0.93 for iSUV alone. The ability of 18F-FDG PET to discriminate between benign and malignant conditions of the central thorax can be improved by correcting the SUV for BSA and by increasing the ‘incubation time’ between 18F-FDG injection and imaging, or by performing narrow time-window dual-point imaging.
- 1 November 2003
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 24 (11) , 1129-1137
Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy
Dual time-point imaging has been proposed as a means of improving the accuracy of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) for the diagnosis of malignant pulmonary nodules. The purpose of this study was to evaluate a dual time-point protocol that has a narrow time window between its initial and its delayed imaging sessions. All patients examined during a 16-month time period, either for the diagnosis of a radiographically indeterminate thoracic lesion or for the staging of non-small-cell carcinoma, were included in the study provided that they completed the dual-point protocol and had either biopsy evidence of malignancy, biopsy evidence of a benign condition involving the thoracic lesion of concern, or clinical and radiographic follow-up consistent with the absence of malignancy. The entire study population was further divided into a central subpopulation, whose index lesions were adjacent to or within the hilum or mediastinum, and a peripheral subpopulation, whose index lesions were non-central. The maximum standardized uptake value (SUV) was measured for each lesion, and various body surface areas (BSAs) and glucose corrections on the SUV were compared using discriminant analysis. BSA corrected SUVs for the initial (iSUV) and the delayed (dSUV) imaging sessions, along with their absolute difference (δSUV) and fractional difference (fSUV) were also compared using discriminant analysis and receiver operating characteristic (ROC) analysis. The study population consisted of 132 patients, of whom 81 had malignancy and 51 were classified as having a benign condition. Thirty-three index lesions were central and 99 were peripheral; 109 had visible uptake and 23 had such low uptake that they were not visible above background. The mean time (±SD) between initial and delayed imaging for the visible lesions was 31.1±9.4 min. With respect to the entire study population, the BSA replacement for body weight gave the best performance among the various SUV corrections examined. In addition, the BSA corrected delayed SUV (dSUV) gave a performance superior to either initial SUV (iSUV), absolute difference in SUV (δSUV) and fractional difference in SUV (fSUV) alone. Performance gains achieved by BSA correction and by dSUV appeared to derive primarily from the central subpopulation, thereby indicating that central lesions tend to behave differently to peripheral ones. For the central subpopulation, ROC analysis also demonstrated improved detection of malignancy from dual-point imaging. The best performance was achieved when the BSA corrected dSUV was at least 2.4, or when the fSUV showed at least a 5% increase from initial to delayed imaging. With the optimal combined dSUV/fSUV strategy, the area under the ROC curve was 0.99, as opposed to 0.96 for dSUV alone, or 0.93 for iSUV alone. The ability of 18F-FDG PET to discriminate between benign and malignant conditions of the central thorax can be improved by correcting the SUV for BSA and by increasing the ‘incubation time’ between 18F-FDG injection and imaging, or by performing narrow time-window dual-point imaging.
- 1 May 2003
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 28 (5) , 408-409
Detection of Late Chest Wall Recurrence of Breast Carcinoma During Tc-99m Sestamibi Parathyroid Scintigraphy
- 1 May 2003
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 28 (5) , 408-409
Detection of Late Chest Wall Recurrence of Breast Carcinoma During Tc-99m Sestamibi Parathyroid Scintigraphy
- 1 December 2002
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 27 (12) , 929-931
Severe Bladder Distortion Mimics Bone Metastasis from Pelvic Rhabdomyosarcoma
- 1 December 2002
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 27 (12) , 929-931
Severe Bladder Distortion Mimics Bone Metastasis from Pelvic Rhabdomyosarcoma
- 1 August 2002
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 27 (8) , 597-598
Delayed Postoperative Stenosis of a Right Hepatic Choledochojejunostomy
- 1 August 2002
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 27 (8) , 597-598
Delayed Postoperative Stenosis of a Right Hepatic Choledochojejunostomy